GGrantIndex
← Leaderboards

John M. Roll

University Of California Los Angeles

$12,949,169
Attributed
$22,577,095
Total exposure
13
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$27,039,904 · 14

By mechanism

UG1$8,440,923 · 1
P20$7,663,047 · 5
U10$7,614,692 · 1
R01$2,876,729 · 3
R21$178,500 · 1
M01$144,513 · 2

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Communities

Research focus

CommunitiesProgramsRuralBaseUniversitiesWashingtonMental HealthTrainingResearch PersonnelAddictionDrug AbuseInstitutionProviderClinical ResearchMedicalMethamphetamineBehavioral HealthAmerican IndiansAreaInstitutesNational Institute Of Drug AbuseClinical Trials NetworkPacific NorthwestEffectiveness

Grant awards (68)

Clinical Trials Network: Pacific Northwest Node$791,361
UG1 · FY2025 · DA
Clinical Trials Network: Pacific Northwest Node (CTN-0082, -0131, -0139 and dissemination library)$597,459
UG1 · FY2025 · DA
Clinical Trials Network: Pacific Northwest Node$1,660,257
UG1 · FY2024 · DA
Clinical Trials Network: Pacific Northwest Node$1
UG1 · FY2023 · DA
Clinical Trials Network: Pacific Northwest Node$653,067
UG1 · FY2022 · DA
Clinical Trials Network: Pacific Northwest Node$872,923
UG1 · FY2021 · DA
Clinical Trials Network: Pacific Northwest Node$806,046
UG1 · FY2021 · DA
Clinical Trials Network: Pacific Northwest Node$270,995
UG1 · FY2021 · DA
Clinical Trials Network: Pacific Northwest Node$12,431
UG1 · FY2021 · DA
Clinical Trials Network: Pacific Northwest Node$1,274,771
UG1 · FY2020 · DA
Clinical Trials Network: Pacific Northwest Node$1,049,999
UG1 · FY2020 · DA
Clinical Trials Network: Pacific Northwest Node$451,613
UG1 · FY2020 · DA
Administrative Core$228,499
P20 · FY2016 · MD · contact PI
Promoting First Relationships: Strengthening Child Attachment in Al Communities$172,210
P20 · FY2016 · MD · contact PI
Contingency Management for the Treatment of Co-Occurring Alcohol and Opiate Use$170,695
P20 · FY2016 · MD · contact PI
Randomized Controlled Trial of Mobile Phone Text Messaging for Smoking Cessafion$94,651
P20 · FY2016 · MD · contact PI
Behavioral Health Collaborative for Rural American Indian Communities$1,096,360
P20 · FY2015 · MD · contact PI
Clinical Trials Network: Pacific Northwest Node$375,407
U10 · FY2015 · DA
Administrative Core$244,414
P20 · FY2015 · MD · contact PI
Contingency Management for the Treatment of Co-Occurring Alcohol and Opiate Use$218,074
P20 · FY2015 · MD · contact PI
Promoting First Relationships: Strengthening Child Attachment in Al Communities$158,786
P20 · FY2015 · MD · contact PI
Randomized Controlled Trial of Mobile Phone Text Messaging for Smoking Cessafion$105,915
P20 · FY2015 · MD · contact PI
Clinical Trials Network: Pacific Northwest Node$1,106,411
U10 · FY2014 · DA
Behavioral Health Collaborative for Rural American Indian Communities$1,095,310
P20 · FY2014 · MD · contact PI
Clinical Trials Network: Pacific Northwest Node$246,050
U10 · FY2014 · DA
Administrative Core$212,015
P20 · FY2014 · MD · contact PI
Contingency Management for the Treatment of Co-Occurring Alcohol and Opiate Use$194,489
P20 · FY2014 · MD · contact PI
Promoting First Relationships: Strengthening Child Attachment in Al Communities$164,915
P20 · FY2014 · MD · contact PI
Clinical Trials Network: Pacific Northwest Node$125,352
U10 · FY2014 · DA
Randomized Controlled Trial of Mobile Phone Text Messaging for Smoking Cessafion$83,326
P20 · FY2014 · MD · contact PI
Clinical Trials Network: Pacific Northwest Node$1,107,695
U10 · FY2013 · DA
Behavioral Health Collaborative for Rural American Indian Communities$1,056,540
P20 · FY2013 · MD · contact PI
Clinical Trials Network: Pacific Northwest Node$296,982
U10 · FY2013 · DA
Contingency Management for the Treatment of Co-Occurring Alcohol and Opiate Use$112,192
P20 · FY2013 · MD · contact PI
Clinical Trials Network: Pacific Northwest Node$110,355
U10 · FY2013 · DA
Administrative Core$100,064
P20 · FY2013 · MD · contact PI
Promoting First Relationships: Strengthening Child Attachment in Al Communities$84,775
P20 · FY2013 · MD · contact PI
Randomized Controlled Trial of Mobile Phone Text Messaging for Smoking Cessafion$50,486
P20 · FY2013 · MD · contact PI
Behavioral Health Collaborative for Rural American Indian Communities$1,214,599
P20 · FY2012 · MD · contact PI
Clinical Trials Network: Pacific Northwest Node$1,117,527
U10 · FY2012 · DA
Contingency Management for the Treatment of Co-Occurring Alcohol and Opiate Use$260,552
P20 · FY2012 · MD · contact PI
Administrative Core$216,868
P20 · FY2012 · MD · contact PI
Promoting First Relationships: Strengthening Child Attachment in Al Communities$172,904
P20 · FY2012 · MD · contact PI
Randomized Controlled Trial of Mobile Phone Text Messaging for Smoking Cessafion$154,408
P20 · FY2012 · MD · contact PI
Clinical Trials Network: Pacific Northwest Node$108,500
U10 · FY2012 · DA
Clinical Trials Network: Pacific Northwest Node$1,138,013
U10 · FY2011 · DA
Clinical Trials Network: Pacific Northwest Node$237,287
U10 · FY2011 · DA
Clinical Trials Network: Pacific Northwest Node$129,619
U10 · FY2011 · DA
Clinical Trials Network: Pacific Northwest Node$1,145,494
U10 · FY2010 · DA
Clinical Trials Network: Pacific Northwest Node$370,000
U10 · FY2010 · DA
Contingency Management: Duration Effects$254,993
R01 · FY2007 · DA · contact PI
Behavior Change: Reinforcemnt Schedule Effects$274,498
R01 · FY2006 · DA · contact PI
Contingency Management: Duration Effects$250,851
R01 · FY2006 · DA · contact PI
Behavior Change: Reinforcemnt Schedule Effects$288,007
R01 · FY2005 · DA
Contingency Management: Duration Effects$250,727
R01 · FY2005 · DA
HUMAN BEHAVIORAL PHARMACOLOGY OF GAMMA HYDROXYBUTYRIC ACID (GHB)$37,536
M01 · FY2005 · RR
HUMAN METHAMPHETAMINE USE: A MODEL$5,197
M01 · FY2005 · RR
Behavior Change: Reinforcemnt Schedule Effects$281,648
R01 · FY2004 · DA
Contingency Management: Duration Effects$240,561
R01 · FY2004 · DA
Human Behavioral Pharmacology of Gamma Hydroxybutyric Acid (GHB)$58,667
M01 · FY2004 · RR
Human Methamphetamine Use: A Model$43,113
M01 · FY2004 · RR
Behavior Change: Reinforcemnt Schedule Effects$274,285
R01 · FY2003 · DA
Human Behavorial Pharmacology of GHB$381,250
R01 · FY2002 · DA
Human Methamphetamine Use: A Model$89,250
R21 · FY2002 · DA
Adolescent Smoking Cessation$60,750
R03 · FY2002 · DA
Behavorial Pharmacology of gamma Hydroxybutyrate$379,909
R01 · FY2001 · DA
Human Methamphetamine Use: A Model$89,250
R21 · FY2001 · DA
Adolescent Smoking Cessation$60,750
R03 · FY2001 · DA